Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies
- PMID: 18404493
- PMCID: PMC2096648
- DOI: 10.1007/s11302-006-9012-4
Characterization of human and rodent native and recombinant adenosine A(2B) receptors by radioligand binding studies
Abstract
Adenosine A(2B) receptors of native human and rodent cell lines were investigated using [(3)H]PSB-298 [(8-{4-[2-(2-hydroxyethylamino)-2-oxoethoxy]phenyl}-1-propylxanthine] in radioligand binding studies. [(3)H]PSB-298 showed saturable and reversible binding. It exhibited a K(D) value of 60 +/- 1 nM and limited capacity (B(max) = 3.511 fmol per milligram protein) at recombinant human adenosine A(2B) receptors expressed in human embryonic kidney cells (HEK-293). The addition of sodium chloride (100 mM) led to a threefold increase in the number of binding sites recognized by the radioligand. The curve of the agonist 5'-N-ethylcarboxamidoadenosine (NECA) was shifted to the right in the presence of NaCl, while the curve of the antagonist PSB-298 was shifted to the left, indicating that PSB-298 may be an inverse agonist at A(2B) receptors. Adenosine A(2B) receptors were shown to be the major adenosine A(2) receptor subtype on the mouse neuroblastoma x rat glioma hybrid cell line NG108-15 cells. Binding studies at rat INS-1 cells (insulin secreting cell line) demonstrated that [(3)H]PSB-298 is a selective radioligand for adenosine A(2B) binding sites in this cell line.
Figures












Similar articles
-
Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.Mol Pharmacol. 1999 Oct;56(4):705-13. Mol Pharmacol. 1999. PMID: 10496952
-
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.Biochem Pharmacol. 2005 Nov 25;70(11):1601-12. doi: 10.1016/j.bcp.2005.08.018. Epub 2005 Oct 10. Biochem Pharmacol. 2005. PMID: 16219300
-
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.J Med Chem. 2009 Jul 9;52(13):3994-4006. doi: 10.1021/jm900413e. J Med Chem. 2009. PMID: 19569717
-
Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.Mol Pharmacol. 2005 Jun;67(6):2137-47. doi: 10.1124/mol.104.009225. Epub 2005 Mar 23. Mol Pharmacol. 2005. PMID: 15788741
-
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists.Curr Pharm Des. 2002;8(26):2285-98. doi: 10.2174/1381612023392856. Curr Pharm Des. 2002. PMID: 12369946 Review.
Cited by
-
Tritium-labeled agonists as tools for studying adenosine A2B receptors.Purinergic Signal. 2018 Sep;14(3):223-233. doi: 10.1007/s11302-018-9608-5. Epub 2018 May 11. Purinergic Signal. 2018. PMID: 29752618 Free PMC article.
-
Xanthines as adenosine receptor antagonists.Handb Exp Pharmacol. 2011;(200):151-99. doi: 10.1007/978-3-642-13443-2_6. Handb Exp Pharmacol. 2011. PMID: 20859796 Free PMC article. Review.
-
Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.Purinergic Signal. 2013 Sep;9(3):395-414. doi: 10.1007/s11302-013-9358-3. Epub 2013 Apr 2. Purinergic Signal. 2013. PMID: 23543220 Free PMC article.
-
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.ACS Med Chem Lett. 2014 Jan 16;5(4):326-30. doi: 10.1021/ml400399f. eCollection 2014 Apr 10. ACS Med Chem Lett. 2014. PMID: 24900835 Free PMC article.
-
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.Purinergic Signal. 2015 Sep;11(3):389-407. doi: 10.1007/s11302-015-9460-9. Epub 2015 Jul 1. Purinergic Signal. 2015. PMID: 26126429 Free PMC article.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.2174/1568026033392264', 'is_inner': False, 'url': 'https://doi.org/10.2174/1568026033392264'}, {'type': 'PubMed', 'value': '12570760', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12570760/'}]}
- Volpini R, Costanzi S, Vittori S et al (2003) Medicinal chemistry and pharmacology of A2B adenosine receptors. Curr Top Med Chem 3:427–33 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1038/sj.bjp.0706272', 'is_inner': False, 'url': 'https://doi.org/10.1038/sj.bjp.0706272'}, {'type': 'PMC', 'value': 'PMC1576223', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1576223/'}, {'type': 'PubMed', 'value': '15980878', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15980878/'}]}
- Holgate ST (2005) The identification of the adenosine A2B receptor as a novel therapeutic target in asthma. Br J Pharmacol 145:1009–015 - PMC - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1124/jpet.103.056036', 'is_inner': False, 'url': 'https://doi.org/10.1124/jpet.103.056036'}, {'type': 'PubMed', 'value': '14563788', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14563788/'}]}
- Abo-Salem OM, Hayallah AM, Bilkei-Gorzo A et al (2004) Antinociceptive effects of novel A2B adenosine receptor antagonists. J Pharmacol Exp Ther 308:358–66 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0165-6147(98)01179-1', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0165-6147(98)01179-1'}, {'type': 'PubMed', 'value': '9612090', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9612090/'}]}
- Feoktistov I, Polosa R, Holgate ST et al (1998) Adenosine A2B receptors: a novel therapeutic target in asthma? Trends Pharmacol Sci 19:148–53 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1021/jm990499b', 'is_inner': False, 'url': 'https://doi.org/10.1021/jm990499b'}, {'type': 'PubMed', 'value': '11170626', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11170626/'}]}
- Harada H, Asano O, Hoshino Y et al (2001) 2-Alkynyl-8-aryl-9-methyladenosines as novel adenosine receptor antagonists: their synthesis and structure–activity relationship toward hepatic glucose production induced via agonism of the A2B receptor. J Med Chem 44:170–79 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous